[ET Net News Agency, 3 November 2025] SIMCERE PHARMA (02096) rose 10.1% to HK$13.61.
It hits an intra-day high of HK$13.62, breaking above the 100-D SMA of HK$12.475, and an
intra-day low of HK$12.23. The total shares traded was 12.22 million, with a value of
HK$159.28m. The active buy/sell ratio is 71:29, with net buying turnover of HK$64.33m.
GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive buying turnover of HK$6.45m,
with volume weighted average price of HK$13.056. CHINA INV INFO accounts for greatest net
responsive selling turnover of HK$16.97m, with volume weighted average price of HK$13.078.
The stock has risen a combined 14.9% over the past 2 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 13.610 % Chg +10.11%
High 13.620 Low 12.230
Shares Tr 12.22m Turnover 159.28m
10-D SMA 12.695 %H.V 51.005
20-D SMA 12.714 VWAP 13.030
50-D SMA 13.156 RSI14 58.143
----------------------------------
Status: Breaking above the 100-D SMA, active buy/sell ratio is 71:29, with net buying
turnover of HK$64.33m, rising a combined 14.9% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
----------------------------------------------
SIMCERE PHARMA (02096) 13.61 +10.11
GRAND PHARMA (00512) 8.80 +6.54
CSPC PHARMA (01093) 7.75 +1.31
SINO BIOPHARM (01177) 7.22 +2.12
HENGRUI PHARMA (01276) 74.25 -1.26
3SBIO (01530) 31.90 +3.57
FOSUN PHARMA (02196) 23.92 +0.42
WUXI APPTEC (02359) 105.00 -3.31
HANSOH PHARMA (03692) 36.62 +2.75
UNITED LAB (03933) 13.01 +3.50
----------------------------------------------
(ed)